All terms in GO
| Label | Id | Description |
|---|---|---|
| regulation of cardiac muscle tissue growth | GO_0055021 | [Any process that modulates the frequency, rate or extent of cardiac muscle growth.] |
| regulation of heart growth | GO_0060420 | [Any process that modulates the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.] |
| negative regulation of cardiac muscle tissue growth | GO_0055022 | [Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle growth.] |
| negative regulation of heart growth | GO_0061117 | [Any process that decreases the rate or extent of heart growth. Heart growth is the increase in size or mass of the heart.] |
| negative regulation of osteoclast differentiation | GO_0045671 | [Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.] |
| regulation of osteoclast differentiation | GO_0045670 | [Any process that modulates the frequency, rate or extent of osteoclast differentiation.] |
| osteoclast differentiation | GO_0030316 | [The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.] |
| positive regulation of osteoclast differentiation | GO_0045672 | [Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.] |
| GO_0045673 | GO_0045673 | |
| vitamin D metabolic process | GO_0042359 | [The chemical reactions and pathways involving vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3).] |
| GO_0045674 | GO_0045674 | |
| vitamin D4 metabolic process | GO_0070641 | [The chemical reactions and pathways involving vitamin D4, (3S,5Z,7E)-9,10-secoergosta-5,7,10(19)-trien-3-ol.] |
| GO_0045675 | GO_0045675 | |
| vitamin D5 metabolic process | GO_0070642 | [The chemical reactions and pathways involving vitamin D5, (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R,4S)-4-ethyl-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-1-cyclohexanol.] |
| regulation of R7 cell differentiation | GO_0045676 | [Any process that modulates the frequency, rate or extent of R7 differentiation.] |
| R7 cell differentiation | GO_0045466 | [The process in which a relatively unspecialized cell acquires the specialized features of the R7 photoreceptor.] |
| vitamin D 25-hydroxylase activity | GO_0070643 | [Catalysis of the hydroxylation of C-25 of any form of vitamin D.] |
| vitamin D response element binding | GO_0070644 | [Interacting selectively and non-covalently with the vitamin D response element (VDRE), a short sequence with dyad symmetry found in the promoters of some of the cellular immediate-early genes, regulated by serum.] |
| Ubisch body | GO_0070645 | [A small, granular structure that is found in the extracellular matrix of cell of the secretory tapetal layer that surrounds developing pollen grains. Ubisch bodies have a sporopollenin coat, are attached to the peritapetal wall, and may play a role in pollen development.] |
| protein modification by small protein conjugation or removal | GO_0070647 | [A protein modification process in which one or more groups of a small protein, such as ubiquitin or a ubiquitin-like protein, are covalently attached to or removed from a target protein.] |